All News about Vaxxinity, Inc. - Class A Common Stock
Vaxxinity Announces Board Appointments and Establishes New Headquarters in Florida
February 01, 2023
From Vaxxinity, Inc.
Via GlobeNewswire
Vaxxinity Starts Dosing In Phase 1 Migraine Vaccine Trial
September 13, 2022
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 23, 2023
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 20, 2023
Via Benzinga
Vaxxinity to Present at the 2023 J.P. Morgan Healthcare Conference
January 05, 2023
From Vaxxinity, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 29, 2022
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 07, 2022
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 02, 2022
Via Benzinga
Vaxxinity Announces Positive Topline Pivotal Phase 3 COVID-19 Booster Data for UB-612
December 02, 2022
From Vaxxinity, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
December 01, 2022
Via Benzinga
Vaxxinity Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 10, 2022
From Vaxxinity, Inc.
Via GlobeNewswire
From Vaxxinity, Inc.
Via GlobeNewswire
Vaxxinity to Present at Upcoming Investor Conferences in November
November 01, 2022
From Vaxxinity, Inc.
Via GlobeNewswire
Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary
September 13, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.